37 Katz DL, O'Connell M, Njike VY, et al. Strategies for the prevention and control of obesity in the school setting: systematic review and meta-analysis. Background: Israel is ranked second among OECD countries in diabetes mortality despite good performance on diabetes care measures. This study assessed whether variations in death certification practices could explain differences in diabetes mortality rates between countries, using a comparison between the USA and Israel as an example. Methods: Multiple cause mortality data for Israel and the USA were analyzed. The proportions of cases with diabetes coded as the underlying cause of death (UCOD), of all certificates with diabetes listed as one of the multiple causes of death (MCOD), were calculated by age-group, and compared between the USA and Israel, with emphasis on cases in which cardiovascular events were reported in part I of the certificate. Results: The diabetes UCOD/MCOD ratio was higher in Israel for all age groups. The differences in proportions were larger when cardiovascular events were reported in part I. Diabetes mortality rate ratio between the countries would be 49% lower if the UCOD/MCOD ratios in US data were applied to the Israeli data. Conclusions: Half of the difference in the reported diabetes mortality rate between the USA and Israel is explained by different coding practices. International comparisons could be improved by using multiple cause data or by clarifying guidelines regarding certification of diabetes deaths.
Introduction

I
srael is ranked second among OECD countries in reported diabetes mortality. 1, 2 Since the prevalence of diabetes in Israel is similar to the OECD average 2 this could imply a higher case fatality rate of diabetic patients in Israel. In contrast, the mortality rates in Israel from stroke and ischemic heart disease (IHD), two conditions closely related to diabetes, are among the lowest in the OECD. 1 These conflicting findings could be attributed to differences in death certification practices relating to diabetes, specifically, when and how often diabetes is reported and selected as the underlying cause of death (UCOD).
The National Center for Health Statistics in the USA developed multiple-cause coding in order to address the fact that many deaths are caused by the association of several chronic diseases. This coding of mortality data has been used in the USA since 1968. 3 Multiplecause coding is now widely used in many countries including Israel. However, official statistics and international comparisons are still based solely on the UCOD. 4, 5 According to WHO selection rules, in cases of death from an acute disease that can be caused by diabetes (e.g. IHD, renal failure), diabetes can be reported either in part I of the death certificate, possibly as the UCOD, or in part II as a contributing cause. 6 The decision as to how to record diabetes is in the discretion of the physician who completes the death certificate, based on the medical data available to him and his clinical judgment regarding the sequence of events that led to the death. This subjective classification is the source of considerable variability between physicians as well as in mortality statistics between countries. 7, 8 Previous studies demonstrated that the proportion of deaths with diabetes as the UCOD, of all deaths with diabetes as one of the multiple causes of death (MCOD) varies between countries. UCOD/MCOD was reported as 0.22 in Sweden, 0.24 in Italy, 0.3 in the USA, 0.39 in France and 0.5 in Taiwan. 7, 9, 10 . Furthermore, this proportion can vary with time 9, 11, 12 and with the characteristics of the deceased or the certifier. 13, 14 One study compared certifications of causes of death of diabetic subjects by providing 220 certifying physicians from six European countries with six case histories describing death cases of diabetic patients. 15 Large variation was found in cases in which the deceased were long-time diabetes patients and died from acute cardiovascular events such as stroke or myocardial infarction. 15 A study from Sweden showed that variation in coding chronic diseases, including diabetes, as the UCOD or a MCOD may occur on a regional level within the same country. 16 Age-adjusted diabetes mortality rates are consistently considerably higher in Israel than in the USA; in 2010 the rates were 42.4 per 100 000 in Israel and 23.2 per 100 000 in the USA. In this study, we used multiple cause mortality data to examine whether differences in death certification practices could explain in part the differences in reported diabetes mortality rates between the USA and Israel.
Methods
Data sources
Multiple cause mortality data were obtained from the Israeli Central Bureau of Statistics for the years 2007-11. We chose to compare Israeli data to those of the USA, as the MCOD data files from the USA are available for public use and the age-adjusted prevalence of diabetes in the USA is relatively similar to that in Israel (the estimated prevalence among adults is 7.6 % in Israel and 9.2 % in the USA. 1 For the USA, we obtained multiple-cause mortality data available from the Centers for Disease Control for the year 2010.
The following ICD10 codes were used to classify causes of death: E10-E14 for diabetes, I20-I25 for IHD and I60-I69 for cerebrovascular disease.
Analyses
For the year 2010, crude, age-adjusted and age-specific mortality rates for diabetes as the UCOD and as one of the MCOD were compared between the USA and Israel, using the US 2010 population as the standard. Diabetes mortality rates between Israel and the USA were compared by calculation of the age-specific mortality rate ratios of diabetes as the UCOD and as one of the MCOD. The proportions of cases with diabetes reported in part I of the death certificate and of diabetes as the UCOD, of all certificates with diabetes as one of the MCOD, were calculated by agegroup for USA and Israel data, and compared using chi-square test. To assess variation in reporting practices in cases of IHD together with diabetes, we extracted all cases for which IHD was reported in part I and diabetes was one of the MCOD. We calculated in this group, the proportion in which diabetes was selected as the UCOD. The same comparison was done for cerebrovascular disease. To provide a sufficient number of cases for these comparisons in each age-group, these analyses were performed on mortality data from Israel for the years 2007-11combined.
Results
In 2010, the diabetes crude mortality rate was 28.3 per 100 000 in Israel and 22.4 per 100 000 in the USA. The age-adjusted diabetes mortality rate was significantly higher in Israel (29.9 per 100 000 vs. 17.4 per 100 000). Diabetes was listed as one of the MCOD on 6292 of 39 418 death certificates in Israel (16.0% of all deaths) and was selected as the UCOD in 2,280 (5.8%) of them, rendering the UCOD/MCOD proportion 36.2%. The comparable figures in the USA were 234 330 of 2 472 542 (9.5%) for diabetes as MCOD, 69 134 (2.8%) for diabetes as the UCOD and 29.5% for UCOD/MCOD.
The age-adjusted rate ratio between the countries was higher for diabetes as the UCOD than as a MCOD (RR1.71; 95% CI 1.62-1.81 vs. RR1.42; 95% CI 1.28-1.46).
Age-specific mortality rates from diabetes as the UCOD and as a MCOD in Israel and the USA are shown in Table 1 . Mortality rates were higher in the US than in Israel in the younger age groups, up to age 64 years. In contrast in ages 65 years and above, mortality rates were higher in Israel, and the rate ratio increased with age. Similar trends were found for mortality when diabetes was listed as the UCOD or as one of the MCOD. Table 2 presents the proportions of deaths with diabetes reported as the UCOD, of all death certificates with diabetes listed as a MCOD, by age groups in both countries. As can be seen, these proportions were relatively similar in both countries for the younger age groups, but lower in the USA for the older age groups, reaching 27% in ages 85 years and older, compared with 40% in this age group in Israel. Applying the US UCOD/MCOD ratios to the Israeli diabetes mortality data would lower the ageadjusted diabetes mortality rate from 29.9 to 23.5 per 100 000, thus reducing the rate ratio between the countries by 49%, from 1.71 to 1.35 (Table 2) .
In 14 107 Israeli death certificates and 61 922 American certificates, diabetes was listed as a MCOD and IHD or cerebro-vascular disease was listed in part I. For these cases, diabetes was reported in part I in about 60% of the death certificates in Israel compared with only 35-39% in the USA (P < 0.001; Table 3 ).
When an IHD event was coded in part I in the presence of diabetes, the proportion of certificates in which diabetes was selected as the UCOD was significantly higher in Israel in all age groups above 54 years (Supplementary figure S1A). The largest difference was observed in the oldest age group: diabetes was selected as the UCOD in 42% of certificates in Israel compared with only 30.6% in the USA (P < 0.0001).
Similarly, in cases in which cerebrovascular disease was reported in part I and diabetes was reported as a MCOD, diabetes was selected as the UCOD in 9-12% more cases in Israel than in the USA, in all age groups above 45 years (Supplementary figure S1B).
Discussion
In this study, we demonstrated that variation in coding practices could cause spurious differences in reported diabetes mortality rates between countries. In this case, such variation explained 49% of the difference between reported diabetes mortality rates in Israel and the USA. When compared with the USA, physicians in Israel tend to report diabetes more often in part I of the death certificate and thus, diabetes has a greater chance of being selected as the UCOD. The proportion of death certificates in which diabetes was selected as the UCOD, of all the certificates with diabetes as one of the MCOD, was similar in the younger age groups, suggesting that in this age range it is easier to determine when diabetes is the UCOD. In contrast, in the older age groups, comorbid conditions make the decision more complex and more susceptible to the influence of individual judgement. Although in the USA the UCOD/MCOD ratio decreased with age, in Israel it remained fairly stable, supporting the possibility of coding practice variations between the countries as a cause for differences in reported diabetes mortality rates. According to WHO coding rules, in case of death caused by a terminal cardio-circulatory event, diabetes can be selected as the UCOD if the certifier believes the cardiovascular disease was a direct consequence of the diabetes. These rules leave much freedom for subjective judgment and possible variation between certifiers. It has been demonstrated that, given the same medical scenario, physicians vary in the decision as to whether to select diabetes as the UCOD or as a contributing cause. 15, 17 Variability was also observed between countries and between different time periods in the same country. 11, 12, 18 Thus, physicians in Taiwan tended to report diabetes more often in part I than did doctors in Sweden and Australia, 18 similar to the difference between Israeli and USA practices reported herein. Theoretically, a number of explanations are possible. For one, physicians in different countries may have different views regarding the role of diabetes in the medical events leading to death. More specifically, the attention given globally as well as locally in Israel, to the growing burden of diabetes, may increase the importance Israeli physicians attribute to diabetes in the sequence of events leading to death. It is also possible that lack of knowledge regarding the significance of the order in which the causes of death are listed leads to listing diabetes in part I instead of part II, thus causing misclassification of the UCOD. Supporting this possibility is the finding that the proportion of certificates with diabetes selected as the UCOD of all certificates with diabetes listed in part I, was much higher in the USA than In Israel. This gap reflects the difference between the way physicians completed the death certificate and the correct coding rules for UCOD determination. It may imply lower awareness of physicians in Israel to the guidelines for correct completion of death certificates.
As diabetes is a known risk factor for cardiovascular mortality, we analyzed specifically the reporting of IHD or cerebrovascular disease in part I in the presence of diabetes. We found that in almost all age groups, diabetes was more likely to be selected as the UCOD in Israel than in the USA. The difference between the countries was greater in the older age groups for which more deaths occur, thus increasing asymmetrically the difference in reported diabetes mortality rates between the countries. The proportions of diabetes as the UCOD in the oldest age group were 42% in Israel vs. 30.6% in the USA for cases of IHD, and 42.1 vs. 29.1%, respectively, for cases of cerebrovascular disease. In parallel, reported rates of mortality from IHD and cerebrovascular disease are much lower in Israel than in the USA. This difference may be due in part to the difference in diagnoses selected as the UCOD. The major contribution of the association between circulatory disease and diabetes to differences in coding practices between countries was previously demonstrated in the EUrODAB study which compared death certificate coding practices relating to diabetes in nine European countries. 19 These findings highlight the difficulties discussed by Gittelson 20 in making international comparisons based solely on the UCOD, and discerning between true differences in mortality rates versus variations in coding practices. Recent studies from Italy, France and England showed that mortality statistics based on the UCOD as compared with multiple cause analysis lead to significant underestimation of diabetes related mortality. 7, 10, 21 Furthermore, the MCOD approach can better expose and characterize existing associations between diseases. 10, 22 The higher diabetes mortality rates, according to MCOD, which were observed in Israel, could reflect a higher prevalence of diabetes in the elderly in Israel. Previous studies found associations between increased mortality rates of diabetes as MCOD and changes in diabetes prevalence. 9, 21 According to MCOD data, people with diabetes die earlier in the USA (46% of the deceased with any mention of diabetes were younger than 75 vs. 33% in Israel) and this could lead to higher prevalences of diabetes in the older age groups in Israel. However, in addition, there may be a greater tendency in Israel to document diabetes on death certificates of people who die with diabetes. Future studies should explore this possibility.
In conclusion, this study found that in Israel, high reported diabetes mortality rates were partially explained by a higher propensity of physicians to record diabetes in part I of the death certificate and to select it as the UCOD, especially in the presence of an acute cardiovascular event. This bias could be avoided if international comparisons incorporated MCOD data as well, and did not rely solely on UCOD statistics. As the majority of deaths are caused by chronic diseases and involve several organs and systems, using MCOD data for international comparisons could provide a more reliable comparison, while eliminating the variability and subjectivity inherent to the UCOD selection process. In addition, clearer guidelines regarding the certification of diabetes deaths with specific reference to cardiovascular diseases should be formulated.
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Key points
Variations in death certification practices may cause spurious differences in reported diabetes mortality rates between countries. 49% of the difference in reported diabetes mortality rates between Israel and the USA appear to be attributed to differences in coding diabetes deaths Attribution of death to diabetes is affected by the subjective view of the certifying physician, especially in cases of cardiovascular fatal events. Clearer guidelines regarding the certification of diabetes deaths should be formulated. International organizations should adopt the usage of multiple causes of death data for comparative statistics in order to achieve a less biased comparison of diabetes-related deaths.
